Why Treatment Must Change and What Patients Can Do Antonio C. Bianco, MD Dr. Bianco's long-awaited book is now available from the University of Chicago Press in several formats. A quick scan until I have the time to read it thoroughly brings out some mind blowing but not unexpected r4esearch based concepts – that many… Continue reading Rethinking Hypothyroidism
The first step to adding T3 to our thyroid hormone replacement regimen following total thyroidectomy (TT) is understanding what T3 is and how it works. The two thyroid hormones are thyroxine (T4) and triiodothyronine (T3). A healthy thyroid produces mostly T4 and smaller amounts of T3. This production is controlled by a “negative feedback loop”… Continue reading Basic T3 Startup
Why is TSH suppression so often the sole or primary goal in thyroid cancer treatment with little regard for Quality of Life (QoL)? We are told, over and over, that the vast majority of thyroid cancer patients do just fine for the rest of their lives on synthetic thyroid hormone replacement (THR) therapy evaluated by… Continue reading Suppression vs QoL
— From the publisher's press release:New Rochelle, NY, February 18, 2021—Combination therapy with levothyroxine (LT4) and liothyronine (LT3) is widely used to treat hypothyroidism despite clinical trial results not showing a consistent benefit. A new consensus statement, which presents evidence to support the use of LT4/LT3 combinations and to guide future clinical trial development, is… Continue reading New Consensus on Combination Therapy to Treat Hypothyroidism
Thyroid Cancer Advocates 